| Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128· 9 million … L Abarca-Gómez, ZA Abdeen, ZA Hamid, NM Abu-Rmeileh, ... The lancet 390 (10113), 2627-2642, 2017 | 8268 | 2017 |
| Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19· 2 million participants NCD Risk Factor Collaboration Lancet (London, England) 387 (10026), 1377, 2016 | 5762 | 2016 |
| Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4· 4 million participants B Zhou, Y Lu, K Hajifathalian, J Bentham, M Di Cesare, G Danaei, H Bixby, ... The lancet 387 (10027), 1513-1530, 2016 | 4293 | 2016 |
| Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19· 1 million participants B Zhou, J Bentham, M Di Cesare, H Bixby, G Danaei, MJ Cowan, ... The Lancet 389 (10064), 37-55, 2017 | 2821 | 2017 |
| Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 … B Zhou, RM Carrillo-Larco, G Danaei, LM Riley, CJ Paciorek, GA Stevens, ... The Lancet 398 (10304), 957-980, 2021 | 2338 | 2021 |
| Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 … TGBMRF Effects). | 989* | 2013 |
| Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study M Cuchel, EA Meagher, H du Toit Theron, DJ Blom, AD Marais, ... The Lancet 381 (9860), 40-46, 2013 | 829 | 2013 |
| Rising rural body-mass index is the main driver of the global obesity epidemic in adults Nature 569 (7755), 260-264, 2019 | 765 | 2019 |
| A century of trends in adult human height NCD Risk Factor Collaboration (NCD-RisC) elife 5, e13410, 2016 | 644 | 2016 |
| A novel component of the metabolic syndrome: the oxidative stress E Hopps, D Noto, G Caimi, MR Averna Nutrition, Metabolism and Cardiovascular Diseases 20 (1), 72-77, 2010 | 470 | 2010 |
| Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based … A Rodriguez-Martinez, B Zhou, MK Sophiea, J Bentham, CJ Paciorek, ... The Lancet 396 (10261), 1511-1524, 2020 | 399 | 2020 |
| Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score” P Moulin, R Dufour, M Averna, M Arca, AB Cefalù, D Noto, L D'Erasmo, ... Atherosclerosis 275, 265-272, 2018 | 213 | 2018 |
| Repositioning of the global epicentre of non-optimal cholesterol Nature 582 (7810), 73-77, 2020 | 206 | 2020 |
| Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331 288 participants G Danaei, S Fahimi, Y Lu, B Zhou, K Hajifathalian, M Di Cesare, WC Lo, ... The lancet Diabetes & endocrinology 3 (8), 624-637, 2015 | 195 | 2015 |
| Molecular diagnosis of hypobetalipoproteinemia: an ENID review P Tarugi, M Averna, E Di Leo, AB Cefalù, D Noto, L Magnolo, L Cattin, ... Atherosclerosis 195 (2), e19-e27, 2007 | 194 | 2007 |
| Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy S Bertolini S, L Piscotta, C Rabacchi, AB Cefalù, D Noto, T Fasano, ... Atherosclerosis, 2013 | 171 | 2013 |
| A Novel Loss of Function Mutation of PCSK9 Gene in White Subjects With Low-Plasma Low-Density Lipoprotein Cholesterol T Fasano, AB Cefalu, E Di Leo, D Noto, D Pollaccia, L Bocchi, V Valenti, ... Arteriosclerosis, thrombosis, and vascular biology 27 (3), 677-681, 2007 | 167 | 2007 |
| Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia L Pisciotta, CP Oliva, AB Cefalù, D Noto, A Bellocchio, R Fresa, ... Atherosclerosis 186 (2), 433-440, 2006 | 161 | 2006 |
| Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins F Santilli, L Bucciarelli, D Noto, AB Cefalù, V Davì, E Ferrante, C Pettinella, ... Free Radical Biology and Medicine 43 (9), 1255-1262, 2007 | 151 | 2007 |
| Cystatin C levels are decreased in acute myocardial infarction: effect of cystatin C G73A gene polymorphism on plasma levels D Noto, AB Cefalu, CM Barbagallo, A Pace, M Rizzo, G Marino, ... International journal of cardiology 101 (2), 213-217, 2005 | 107 | 2005 |
